Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05604365 · ClinicalTrials.gov registry record · NA
FearLess in Cognitively Intact Patients With Glioma
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT05604365 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 22 participants.
The verdict
NCT05604365, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
Interventions
- BEHAVIORAL FearLess Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2023-11-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05604365
The ClinicalTrials.gov registry entry for NCT05604365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FearLess Intervention is the first listed.
NCT05604365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05604365 about?
NCT05604365 is a clinical study titled "FearLess in Cognitively Intact Patients With Glioma". This study will assess the preliminary feasibility and acceptability of FearLess, a newly-developed psychological intervention for fear of cancer recurrence (FCR) among cognitively-intact patients with glioma.
What is the current status of trial NCT05604365?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2022-11-07. Estimated completion is 2023-11-14.
What interventions are being tested in trial NCT05604365?
The interventions under investigation include: FearLess Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05604365?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.